milrinone has been researched along with ouabain in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Ebbert, M; Janssens, WJ; Leidig, A; Meuter, C; Peters, T; Wilffert, B; Wilhelm, D | 1 |
| Evenou, JP; Hof, A; Hof, RP; Novosel, D | 1 |
| Bethke, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Schmitz, W; Scholz, H; von der Leyen, H | 1 |
| Berdeaux, A; Gérard, JL; Giudicelli, JF; Gosgnach, M | 1 |
| Andersson, KE; Belfrage, P; Degerman, E; Lindgren, S; Manganiello, VC | 1 |
| Berdeaux, A; Gerard, JL; Giudicelli, JF | 1 |
| Evans, DB; Harris, AL; Lemp, BM; Silver, PJ | 1 |
| Al-Wathiqui, MH; Brooks, HL; Gross, GJ; Preuss, KC; Shimshak, TM; Warltier, DC; Wynsen, JC | 1 |
| Langley, AE; Nguyen, DA; Sernka, TJ; Smith, SG | 1 |
| Brown, L; Erdmann, E; Näbauer, M | 1 |
| Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
| Amsterdam, EA; Rendig, SV | 1 |
| Miao, L; Morgan, JP; Perreault, CL; Travers, KE | 1 |
| Onur, R; Yenisehirli, A | 1 |
| Bai, YL; Chen, YY; Chu, QJ; Li, J; Li, WJ; Zhang, Q | 1 |
17 other study(ies) available for milrinone and ouabain
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Topics: Action Potentials; Animals; Benzimidazoles; Carbachol; Female; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Norepinephrine; Ouabain; Oxindoles; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Vasodilator Agents | 1992 |
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart Failure; Heart Rate; Milrinone; Myocardial Contraction; Nitroprusside; Ouabain; Propranolol; Pyridones; Rabbits; Vagotomy; Vasodilator Agents | 1992 |
Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
Topics: Adult; Calcium; Chromatography, DEAE-Cellulose; Electric Stimulation; Female; Heart; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Middle Aged; Milrinone; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Pyridones | 1991 |
Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Topics: Acetylcholine; Animals; Blood Flow Velocity; Cardiotonic Agents; Dobutamine; Dogs; Female; Hemodynamics; Injections, Intra-Arterial; Injections, Intravenous; Male; Milrinone; Nitroglycerin; Norepinephrine; Ouabain; Piperazines; Pyridones; Vasoconstriction; Vasodilation; Vasomotor System | 1991 |
Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels.
Topics: Adult; Aged; Calcium Channel Blockers; Colforsin; Female; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Norepinephrine; Ouabain; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Splanchnic Circulation; Vasodilator Agents | 1989 |
Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Topics: Animals; Autonomic Nervous System; Cardiotonic Agents; Dobutamine; Dogs; Drug Interactions; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Piperazines; Pyridones | 1989 |
The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain.
Topics: Animals; Aorta, Thoracic; Colforsin; Drug Interactions; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Isoproterenol; Isoquinolines; Isosorbide; Milrinone; Nitroprusside; Ouabain; Pyridones; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Vasodilator Agents; Verapamil | 1988 |
Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Dogs; Dopamine; Female; Heart Rate; Hemodynamics; Male; Milrinone; Myocardial Contraction; Ouabain; Pyridazines; Pyridones; Vascular Resistance | 1988 |
Milrinone produces a positive inotropy but is not inhibitory to gastric ion transport.
Topics: Animals; Anions; Biological Transport, Active; Chlorides; Electrophysiology; Female; Guinea Pigs; Male; Milrinone; Myocardial Contraction; Ouabain; Pyridones; Stimulation, Chemical; Stomach | 1986 |
Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium.
Topics: Adult; Calcium; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Ouabain; Papillary Muscles; Pyridones; Rheumatic Heart Disease | 1986 |
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents | 1994 |
Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.
Topics: Animals; Cardiotonic Agents; Culture Techniques; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Milrinone; Models, Cardiovascular; Myocardial Contraction; Ouabain; Papillary Muscles; Pyridones; Rabbits | 1994 |
Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium.
Topics: Aequorin; Animals; Calcium Channel Blockers; Cardiotonic Agents; Carrier Proteins; Enzyme Inhibitors; Ferrets; Heart; Hydralazine; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Procaine; Pyridones; Quinolines; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Tetrodotoxin; Vasodilator Agents; Verapamil | 1997 |
Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Atria; Imidazoles; In Vitro Techniques; Lansoprazole; Male; Milrinone; Myocardial Contraction; Omeprazole; Ouabain; Phosphodiesterase Inhibitors; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Theophylline; Verapamil | 2005 |
A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Topics: Animals; Cardiotonic Agents; Digoxin; Female; Male; Mice; Milrinone; Morphine; Motor Activity; Naloxone; Ouabain; Sodium-Potassium-Exchanging ATPase; Substance Withdrawal Syndrome; Weight Loss | 2012 |